Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007
- PMID: 18992783
- DOI: 10.1016/j.vaccine.2008.10.044
Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007
Abstract
During the period March 1, 1998 to January 14, 2007, approximately 6 million doses of Anthrax vaccine adsorbed (AVA) vaccine were administered. As of January 16, 2007, 4753 reports of adverse events following receipt of AVA vaccination had been submitted to the Vaccine Adverse Event Reporting System (VAERS). Taken together, reports to VAERS did not definitively link any serious unexpected risk to this vaccine, and review of death and serious reports did not show a distinctive pattern indicative of a causal relationship to AVA vaccination. Continued monitoring of VAERS and analysis of potential associations between AVA vaccination and rare, serious events is warranted.
Comment in
-
Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007 [Vaccine 2009;27:290-297].Vaccine. 2009 Nov 12;27(48):6654-5. doi: 10.1016/j.vaccine.2009.08.027. Epub 2009 Aug 27. Vaccine. 2009. PMID: 19716457 No abstract available.
Similar articles
-
Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).Pharmacoepidemiol Drug Saf. 2004 Dec;13(12):825-40. doi: 10.1002/pds.936. Pharmacoepidemiol Drug Saf. 2004. PMID: 15386719 Review.
-
Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):189-202. doi: 10.1002/pds.712. Pharmacoepidemiol Drug Saf. 2002. PMID: 12051118 Review.
-
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.MMWR Surveill Summ. 2003 Jan 24;52(1):1-24. MMWR Surveill Summ. 2003. PMID: 12825543
-
Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007 [Vaccine 2009;27:290-297].Vaccine. 2009 Nov 12;27(48):6654-5. doi: 10.1016/j.vaccine.2009.08.027. Epub 2009 Aug 27. Vaccine. 2009. PMID: 19716457 No abstract available.
-
Gastrointestinal adverse reactions following anthrax vaccination: an analysis of the Vaccine Adverse Events Reporting System (VAERS) database.Hepatogastroenterology. 2004 May-Jun;51(57):762-7. Hepatogastroenterology. 2004. PMID: 15143911
Cited by
-
Recent developments in the understanding and use of anthrax vaccine adsorbed: achieving more with less.Expert Rev Vaccines. 2016 Sep;15(9):1151-62. doi: 10.1586/14760584.2016.1162104. Epub 2016 Mar 25. Expert Rev Vaccines. 2016. PMID: 26942655 Free PMC article. Review.
-
Phase I study of safety and immunogenicity of an Escherichia coli-derived recombinant protective antigen (rPA) vaccine to prevent anthrax in adults.PLoS One. 2010 Nov 5;5(11):e13849. doi: 10.1371/journal.pone.0013849. PLoS One. 2010. PMID: 21079762 Free PMC article. Clinical Trial.
-
Making Common Sense of Vaccines: An Example of Discussing the Recombinant Attenuated Salmonella Vaccine with the Public.Nanoethics. 2014;8(2):179-185. doi: 10.1007/s11569-014-0198-6. Epub 2014 Jul 10. Nanoethics. 2014. PMID: 25152775 Free PMC article.
-
Postexposure Prophylaxis After Possible Anthrax Exposure: Adherence and Adverse Events.Health Secur. 2016 Nov/Dec;14(6):419-423. doi: 10.1089/hs.2016.0060. Epub 2016 Nov 29. Health Secur. 2016. PMID: 27898235 Free PMC article.
-
Anthrax vaccination strategies.Mol Aspects Med. 2009 Dec;30(6):490-502. doi: 10.1016/j.mam.2009.08.006. Epub 2009 Sep 1. Mol Aspects Med. 2009. PMID: 19729034 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials